Manitex Capital Inc.

MNX

CA56342H2000

Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 14:30:00 28/05/2024 BST			5-day change	1st Jan Change
0.25 ^CAD	+11.11%		+11.11%	+8.70%

03-29	Manitex Capital Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	CI
02-28	Manitex Capital Inc. Reports Earnings Results for the Full Year Ended October 31, 2023	CI

Manitex Capital Inc. Announces Resignation of David Ben-David from Its Board of Directors

November 21, 2018 at 10:39 pm

Manitex Capital Inc. announced that Mr. David Ben-David has resigned from its Board of Directors effective immediately.

Latest news about Manitex Capital Inc.

Manitex Capital Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	03-29	CI
Manitex Capital Inc. Reports Earnings Results for the Full Year Ended October 31, 2023	02-28	CI
Manitex Capital Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	28/09/23	CI
Manitex Capital Inc. Announces Board Changes	17/08/23	CI
Manitex Capital Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	28/06/23	CI
Manitex Capital Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023	30/03/23	CI
Manitex Capital Inc. Reports Earnings Results for the Full Year Ended October 31, 2022	24/02/23	CI
Manitex Capital Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022	29/09/22	CI
Manitex Capital Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022	29/06/22	CI
Manitex Capital Inc. Reports Earnings Results for the First Quarter Ended January 31, 2022	31/03/22	CI
Manitex Capital Inc. Reports Earnings Results for the Full Year Ended October 31, 2021	18/02/22	CI
Manitex Capital Inc. Reports Earnings Results for the Third Quarter Ended July 31, 2021	29/09/21	CI
Manitex Capital Inc. Reports Earnings Results for the Second Quarter Ended April 30, 2021	28/06/21	CI
Manitex Capital Inc. Reports Earnings Results for the Full Year Ended October 31, 2020	25/02/21	CI
Manitex Capital Inc. Reports Earnings Results for the Third Quarter Ended July 31, 2020	29/09/20	CI
Valeo Pharma Inc. announced that it has received CAD 1.7 million in funding from Manitex Capital Inc. and other investors	09/07/20	CI
Manitex Capital Inc. Reports Earnings Results for the Second Quarter Ended April 30, 2020	30/06/20	CI
Valeo Pharma Inc. announced that it expects to receive CAD 1 million in funding	29/06/20	CI
Manitex Capital Inc. Reports Earnings Results for the First Quarter Ended January 31, 2020	31/03/20	CI
Manitex Capital Inc. Reports Earnings Results for the Full Year Ended October 31, 2019	27/02/20	CI
Manitex Capital Inc. Reports Earnings Results for the Third Quarter Ended July 31, 2019	30/09/19	CI
Manitex Capital Inc. Reports Earnings Results for the Second Quarter Ended April 30, 2019	28/06/19	CI
Manitex Capital Inc. Reports Earnings Results for the Full Year Ended October 31, 2018	28/02/19	CI
Manitex Capital Inc. Announces Resignation of David Ben-David from Its Board of Directors	21/11/18	CI
Manitex Capital Inc. Appoints Ed Margerrison as President and CEO	09/12/15	CI

Manitex Capital Inc. is a Canada-based Diversified investment company. The Company is specialized in investing in emerging as well as established companies in diversified sectors, including life sciences and sustainable products/technologies. The Company also holds an extensive portfolio in marketable securities in companies in the same fields.

Sector

Pharmaceuticals

Calendar

25/06/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
MANITEX CAPITAL INC.	+8.70%	2.32M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B
PFIZER, INC.	-0.45%	162B